FOSTER CITY, Calif., April 29, 2025--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

• BofA Securities Health Care Conference on Tuesday, May 13 at 11:20 AM Pacific Time

• RBC Capital Markets Global Healthcare Conference on Wednesday, May 21 at 11:30 AM Eastern Time

• Bernstein Annual Strategic Decisions Conference on Thursday, May 29 at 2:30 PM Eastern Time

• Jefferies Global Healthcare Conference on Wednesday, June 4 at 11:05 AM Eastern Time

• Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 10 at 11:20 AM Eastern Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250429296271/en/

Contacts

Jacquie Ross, CFA – Investors
investor_relations@gilead.com